Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


Richard Lindstrom Joins Board of Directors at Ocular Therapeutix, Inc.

BEDFORD, Mass., Nov. 5, 2012 /PRNewswire/ -- Ocular Therapeutix announced today the appointment of internationally acclaimed ophthalmologist, Richard Lindstrom, M.D., to the company's Board of Directors.

Dr. Lindstrom is a board-certified surgeon and recognized leader in ophthalmic pharmaceuticals and cataract, corneal, and refractive surgery.  He is the founder and an attending surgeon of Minnesota Eye Consultants, Adjunct Professor Emeritus at the University of Minnesota Department of Ophthalmology, and advisor to numerous ophthalmic companies throughout the world.  He holds over 30 patents in ophthalmology, and has been at the forefront of the industry's evolutionary changes throughout his career. 

"We are incredibly fortunate to have Dr. Lindstrom join our Board of Directors," stated Amar Sawhney, President and CEO of Ocular Therapeutix, Inc.  "As one of the top thought leaders in the industry, Dr. Lindstrom's input and guidance will be invaluable as we advance our sustained release drugs through clinical trials."

Ocular Therapeutix's sustained release drug technology encapsulates proven and approved drugs within the company's proprietary polyethylene glycol (PEG) hydrogel and releases them in a sustained fashion over a predetermined period of time. 

"Ocular Therapeutix's sustained release technology is an exciting prospect for the world of ophthalmology," stated Richard Lindstrom, MD.  "These drugs have the potential to significantly advance the ophthalmic pharmaceutical industry by eliminating patient compliance issues and putting drug dosing in the hands of the physician."

About Ocular Therapeutix, Inc.:

Founded in November 2006, Ocular Therapeutix, Inc. is a privately held company based in Bedford, MA, focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology. Ocular Therapeutix is focusing on development of drug-eluting intracanalicular plugs for treatment of glaucoma and post-operative pain and inflammation, injectable depots for back-of-the-eye diseases, and an ocular sealant.

SOURCE Ocular Therapeutix, Inc.

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Web 2.0 Latest News
One reason a lot of entrepreneurs flock to cloud-based services for their business is the cost. Native applications require licenses that are either too expensive or require elaborate set-up across all devices. In a recent article on the Entrepreneur, Bask Iyer, the CIO and Senior Vic...
With the advent (or surge in popularity) of cloud computing, our use of the so-called ‘computer operating system’ is coming into question. Given that the cloud exists on the back end to drive power to our ‘endpoint’ devices (in whatever form they may be) today, the way those devices h...
I read an insightful article this morning from Bernard Golden on DZone discussing the DevOps conundrum facing many enterprises today – is it better to build your own DevOps tools or go commercial? For Golden, the question arose from his observations at a number of DevOps Days events h...
Node.js and io.js are increasingly being used to run JavaScript on the server side for many types of applications, such as websites, real-time messaging and controllers for small devices with limited resources. For DevOps it is crucial to monitor the whole application stack and Node.js...
Bill Doerrfeld at Nordic APIs has written today about how APIs are evolving the B2B landscape. This is a particularly interesting article for me, because my personal background is working for an EDI provider, where I linked EDI processes from the private network to the Internet, over 1...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE